Over-the-Counter Monograph Drug User Fee annual performance reports to Congress
Similar Posts
Generic Drugs Forum (GDF) 2024: Regulatory Considerations to Enhance Generic Drug Access – 04/10/2024
Generic Drugs Forum (GDF) 2024: Regulatory Considerations to Enhance Generic Drug AccessBlendHouse LLC. Reading, PA. EIR issued 02/17/2023
Task Description Request Please post to the OII FOIA Electronic Reading Room
Record Date 02/17/2023
Short Title (70 char) BlendHouse LLC. Reading, PA. EIR issued 02/17/2023
FEI Number 3015728839
Firm Name BlendHouse LLC
Record Type EIR
State PA
Establishment Type ManufacturerAccelerated Approval Program
To allow for earlier approval of drugs that treat serious conditions and fill an unmet medical need based on a surrogate endpointNomida.biz – 687590 – 09/12/2024
Unapproved New Drugs/MisbrandedThea Pharma, Inc. – 712416 – 07/09/2025
Unapproved New Drugs/MisbrandedRegulatory Submissions with Real-World Evidence: Successes, Challenges, and Lessons Learned – 09/23/2025
Opening Remarks by Sara Brenner, U.S. Food and Drug Administration
September 23, 2025